{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T04:25:14Z","timestamp":1695788714204},"reference-count":10,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p>Dyspepsia, a common disorder, can present some difficult clinical dilemmas. Physicians should explore some of the more challenging cases of dyspepsia in a setting that fosters interactive dialogue among colleagues, as was the case at the interactive discussion reported below. A panel of experts presented and discussed three case histories. The audience was able to choose from among several options for diagnosis or treatment and recorded their votes by means of an electronic handset. The first case concerned the relationship between continued non\u2010steroidal anti\u2010inflammatory drug (NSAID) use and recurrent upper gastrointestinal (GI) symptoms without ulcer or <jats:italic>Helicobacter pylori<\/jats:italic> infection. The second was a woman with complex upper GI symptoms including heartburn. The last featured a young man with dyspepsia and no alarm symptoms. The first case showed that a standard dose of proton pump inhibitor (PPI) is the best treatment for patients with gastritis who continue to use NSAIDs. The second case revealed that 24\u2010h pH monitoring can be used to establish a relationship between symptoms and reflux episodes. The third case demonstrated that it can be difficult to make a definitive diagnosis based on clinical symptoms, and that patients with endoscopy\u2010negative reflux disease usually respond well to PPI therapy.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2001.00117.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:45:46Z","timestamp":1047354346000},"page":"14-19","source":"Crossref","is-referenced-by-count":2,"title":["Managing the dyspeptic patient\u2013an interactive discussion"],"prefix":"10.1111","volume":"15","author":[{"given":"P.","family":"Malfertheiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Stanghellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010P.","family":"Galmiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.H.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7118.1284"},{"key":"e_1_2_3_3_2","unstructured":"DelaneyBC InnesMA DeeksJ.Initial management strategies for dyspepsia.Cochrane Database System Rev2000; CD001961."},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92023-0"},{"key":"e_1_2_3_5_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1742-1241.1999.tb11765.x","article-title":"A trial of a test\u2010and\u2010trial strategy for Helicobacter pylori dyspeptic patients in general practice.","volume":"53","author":"Jones R","year":"1999","journal-title":"Int J Clin Pract"},{"key":"e_1_2_3_6_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1155\/2000\/978035","article-title":"Test and treat strategies for Helicobacter pylori in uninvestigated dyspepsia: a Canadian economic analysis.","volume":"14","author":"Marshall JK","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012030-00010"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.5.618"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00363.x"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.125296000.x"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7282.344"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00117.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00117.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00117.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:41:50Z","timestamp":1695732110000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00117.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":10,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00117.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00117.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}